Top Pharmaceuticals companies in Spain by Price to Sales Ratio (P/S)

This ranking features the top 13 Pharmaceuticals companies in Spain ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 2.78, for January 15, 2025.
#
Name
Price to Sales Ratio (P/S)
Reported Date
Stock Price
Change
Price (30 days) Country
1

7.75

Jan. 14, 2025 USD 77.86 1.89%

Spain

2

6.96

Jan. 13, 2025 USD 1.80 0.04%

Spain

3

6.25

Jan. 14, 2025 USD 1.51 -0.07%

Spain

4

3.34

Jan. 14, 2025 USD 59.78 -0.59%

Spain

5

2.17

Jan. 14, 2025 USD 33.70 0.30%

Spain

6

2.16

Jan. 14, 2025 USD 3.46 -1.45%

Spain

7

1.89

Jan. 14, 2025 USD 1.76 1.20%

Spain

8

1.86

Jan. 14, 2025 USD 8.60 3.71%

Spain

9

1.25

Jan. 14, 2025 USD 3.66 0.89%

Spain

10

0.80

Jan. 14, 2025 USD 9.29 3.24%

Spain

11

0.70

Jan. 14, 2025 USD 9.87 0.82%

Spain

12

0.59

Jan. 14, 2025 USD 2.59 -1.36%

Spain

13

0.42

Jan. 14, 2025 USD 3.65 0.32%

Spain

Frequently Asked Questions
  • Which Pharmaceuticals company in Spain has the highest Price to Sales Ratio (P/S) ?

    The Pharmaceuticals company in Spain with the highest Price to Sales Ratio (P/S) is Pharma Mar, S.A. (MCE: PHM.MC) at 7.75.

  • Which Pharmaceuticals company in Spain has the lowest Price to Sales Ratio (P/S) ?

    The Pharmaceuticals company in Spain with the lowest Price to Sales Ratio (P/S) is Ercros, S.A. (MCE: ECR.MC) at 0.42.